R2 Technology has unveiled at the RSNA meeting a robust version of computer-aided detection technology programmed to find colon polyps. The company plans to take this latest iteration of CAD, first shown at the 2002 RSNA meeting, to the FDA in next year.
R2 Technology has unveiled at the RSNA meeting a robust version of computer-aided detection technology programmed to find colon polyps. The company plans to take this latest iteration of CAD, first shown at the 2002 RSNA meeting, to the FDA in next year.
"This is going to be one of the hottest CAD areas because it will open up virtual colonoscopy as a modality itself," said R2 CEO Michael Klein.
One reason virtual colonoscopy has not taken off is the difficulty physicians have reading the images, according to Klein. Another reason is that patients still must evacuate the colon before the examination. CAD could help alleviate both problems
CAD for colonoscopy has the potential to speed up the exam and eliminate the need to prep the bowel. R2's virtual colonoscopy system can electronically remove stool from colon scans by distinguishing differences in density between fecal material and polyps.
The system also simplifies interpretation of virtual colonoscopy scans. By taking radiologists directly to areas where suspicious nodules may be present, CAD may trim interpretation time down to a few minutes, Klein said.
Contrast-Enhanced Mammography and Dense Breasts: What a New Meta-Analysis Reveals
May 1st 2024The 10-study meta-analysis demonstrated that contrast-enhanced mammography has a 95 percent sensitivity rate and an 81 percent specificity rate for diagnosing suspicious lesions in women with dense breasts.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.